CLINICAL_TRIALS
trial_result
· 2016-02-24
Clinical Trial Update: Oxytocin as Adjunctive Therapy for Schizophrenia [Phase 2]
Summary
A Phase 2 clinical trial evaluating oxytocin as adjunctive therapy for schizophrenia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: IRCCS Centro San Giovanni di Dio Fatebenefratelli | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED